274 related articles for article (PubMed ID: 19286261)
1. Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines.
Moghimi SM; Andresen TL
Mol Immunol; 2009 May; 46(8-9):1571-2. PubMed ID: 19286261
[TBL] [Abstract][Full Text] [Related]
2. Nanomedical engineering: shaping future nanomedicines.
Luo D; Carter KA; Lovell JF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
[TBL] [Abstract][Full Text] [Related]
3. Delivering cancer stem cell therapies - a role for nanomedicines?
Schätzlein AG
Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
[TBL] [Abstract][Full Text] [Related]
4. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth.
Moghimi SM
J Control Release; 2014 Sep; 190():556-62. PubMed ID: 24746624
[TBL] [Abstract][Full Text] [Related]
5. Medical nanotechnology: evolving appropriate risk tools.
Moore R
Med Device Technol; 2007 Sep; 18(5):36-7. PubMed ID: 17939370
[TBL] [Abstract][Full Text] [Related]
6. Complement system and the brain: selected pathologies and avenues toward engineering of neurological nanomedicines.
Lettiero B; Andersen AJ; Hunter AC; Moghimi SM
J Control Release; 2012 Jul; 161(2):283-9. PubMed ID: 22094105
[TBL] [Abstract][Full Text] [Related]
7. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine.
Bawa R
IDrugs; 2007 Jul; 10(7):455-8. PubMed ID: 17642014
[No Abstract] [Full Text] [Related]
8. Future approaches of nanomedicine in clinical science.
Brewer M; Zhang T; Dong W; Rutherford M; Tian ZR
Med Clin North Am; 2007 Sep; 91(5):963-1016. PubMed ID: 17826113
[TBL] [Abstract][Full Text] [Related]
9. New technology and clinical applications of nanomedicine.
Zuo L; Wei W; Morris M; Wei J; Gorbounov M; Wei C
Med Clin North Am; 2007 Sep; 91(5):845-62. PubMed ID: 17826105
[TBL] [Abstract][Full Text] [Related]
10. The emerging nanomedicine landscape.
Wagner V; Dullaart A; Bock AK; Zweck A
Nat Biotechnol; 2006 Oct; 24(10):1211-7. PubMed ID: 17033654
[No Abstract] [Full Text] [Related]
11. [What is Nanomedicine? Nanotechnology for most of the patients!].
Müller B
Rev Med Suisse; 2012 Jan; 8(325):152-3. PubMed ID: 22338491
[No Abstract] [Full Text] [Related]
12. Nanoparticles for thermal cancer therapy.
Day ES; Morton JG; West JL
J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133
[TBL] [Abstract][Full Text] [Related]
13. Exploring emerging nanobiotechnology drugs and medical devices.
Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
[No Abstract] [Full Text] [Related]
14. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
Elder JB; Liu CY; Apuzzo ML
Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
[TBL] [Abstract][Full Text] [Related]
15. [Importance of nanobiology and nanomedicine].
Xie SS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):469-71. PubMed ID: 16995294
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology and cancer nanomedicine.
Liang XJ
Biotechnol Adv; 2014; 32(4):665. PubMed ID: 24913056
[No Abstract] [Full Text] [Related]
17. The nanolight revolution is coming.
Lim X
Nature; 2016 Mar; 531(7592):26-8. PubMed ID: 26935679
[No Abstract] [Full Text] [Related]
18. Establishing nanomedicine.
Kostarelos K
Nanomedicine (Lond); 2006 Oct; 1(3):259-60. PubMed ID: 17716156
[No Abstract] [Full Text] [Related]
19. Nanotechnological strategies for therapeutic targeting of tumor vasculature.
Ding Y; Li S; Nie G
Nanomedicine (Lond); 2013 Jul; 8(7):1209-22. PubMed ID: 23837858
[TBL] [Abstract][Full Text] [Related]
20. Carbon nanotubes as nanomedicines: from toxicology to pharmacology.
Lacerda L; Bianco A; Prato M; Kostarelos K
Adv Drug Deliv Rev; 2006 Dec; 58(14):1460-70. PubMed ID: 17113677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
